149 related articles for article (PubMed ID: 8299806)
1. The "red queen" and endometrial hyperplasia.
Gambrell RD
Fertil Steril; 1994 Feb; 61(2):401-2. PubMed ID: 8299806
[No Abstract] [Full Text] [Related]
2. Effects of hormone replacement therapy on the endometrium and lipid parameters: a review of randomized clinical trials, 1985 to 1995.
Pickar JH; Thorneycroft I; Whitehead M
Am J Obstet Gynecol; 1998 May; 178(5):1087-99. PubMed ID: 9609589
[TBL] [Abstract][Full Text] [Related]
3. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
[TBL] [Abstract][Full Text] [Related]
4. The uterus and the menopause.
Rees MC
Baillieres Clin Obstet Gynaecol; 1996 Sep; 10(3):419-32. PubMed ID: 8931903
[TBL] [Abstract][Full Text] [Related]
5. Estrogen-progestin replacement therapy and endometrial cancer.
Pike MC; Peters RK; Cozen W; Probst-Hensch NM; Felix JC; Wan PC; Mack TM
J Natl Cancer Inst; 1997 Aug; 89(15):1110-6. PubMed ID: 9262248
[TBL] [Abstract][Full Text] [Related]
6. [Ultrasonic evaluation of endometrial changes induced by cyclic sequential hormone substitution therapy].
Berardesca C; Chiechi LM; Caradonna F; Loizzi V; Loizzi P
Minerva Ginecol; 1998 Dec; 50(12):503-5. PubMed ID: 10069161
[TBL] [Abstract][Full Text] [Related]
7. Re: estrogen-progestin replacement therapy and endometrial cancer.
McKnight B; Voigt LF; Beresford SA; Weiss NS
J Natl Cancer Inst; 1998 Jan; 90(2):164-6. PubMed ID: 9450582
[No Abstract] [Full Text] [Related]
8. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
[TBL] [Abstract][Full Text] [Related]
9. Endometrial cancer risk in estrogen users after switching to estrogen-progestin therapy.
Chubak J; Doherty JA; Cushing-Haugen KL; Voigt LF; Saltzman BS; Hill DA; Beresford SA; Weiss NS
Cancer Causes Control; 2007 Nov; 18(9):1001-7. PubMed ID: 17653829
[TBL] [Abstract][Full Text] [Related]
10. Practical aspects of hormone replacement therapy.
Thorneycroft IH
Prog Cardiovasc Dis; 1995; 38(3):243-54. PubMed ID: 7494885
[TBL] [Abstract][Full Text] [Related]
11. Recent studies bring risks, benefits of hormone replacement therapy under scrutiny.
Friedrich MJ
J Natl Cancer Inst; 2001 Sep; 93(17):1287-8. PubMed ID: 11535698
[No Abstract] [Full Text] [Related]
12. Development of endometrial cancer in women on estrogen and progestin hormone replacement therapy.
McGonigle KF; Karlan BY; Barbuto DA; Leuchter RS; Lagasse LD; Judd HL
Gynecol Oncol; 1994 Oct; 55(1):126-32. PubMed ID: 7959253
[TBL] [Abstract][Full Text] [Related]
13. Withdrawal bleeding and endometrial safety.
Padwick M
Lancet; 1994 Dec; 344(8938):1703-4. PubMed ID: 7996980
[No Abstract] [Full Text] [Related]
14. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia: a Cochrane review summary.
Roberts H; Hickey M; Lethaby A
Maturitas; 2014 Jan; 77(1):4-6. PubMed ID: 24182544
[No Abstract] [Full Text] [Related]
15. Estrogen-progestin increases breast cancer risk.
Stephens MB
J Fam Pract; 2000 Apr; 49(4):301-2. PubMed ID: 10778832
[No Abstract] [Full Text] [Related]
16. Postmenopausal estrogens--opposed, unopposed, or none of the above.
Willett WC; Colditz G; Stampfer M
JAMA; 2000 Jan; 283(4):534-5. PubMed ID: 10659883
[No Abstract] [Full Text] [Related]
17. Progesterone and endometrial cancer.
Gompel A
Best Pract Res Clin Obstet Gynaecol; 2020 Nov; 69():95-107. PubMed ID: 32732107
[TBL] [Abstract][Full Text] [Related]
18. Postmenopausal hormone replacement therapy use and risk of endometrial cancer in Japanese women.
Mizunuma H; Honjo H; Aso T; Urabe M; Ohta H; Kobayashi S; Sagara Y; Sanada M; Tanaka K; Dobashi K; Hayashi K; Ohama K
Climacteric; 2001 Dec; 4(4):293-8. PubMed ID: 11770185
[TBL] [Abstract][Full Text] [Related]
19. Reversal by medical treatment of endometrial hyperplasia caused by estrogen replacement therapy.
Figueroa-Casas PR; Ettinger B; Delgado E; Javkin A; Vieder C
Menopause; 2001; 8(6):420-3. PubMed ID: 11723414
[TBL] [Abstract][Full Text] [Related]
20. The endometrium--from estrogens alone to TSECs.
Pickar JH
Climacteric; 2009 Dec; 12(6):463-77. PubMed ID: 19905899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
